Allergy Diagnostics Market

2021 Analysis and Review: Allergy Diagnostics Market By Product Type – Fungal Allergy Diagnostic and Neutral Lactase Enzymes for 2021 – 2031

Key Highlights from Report

  • How Will The Allergy Diagnostics Market Grow In The Future?

    According to FMI, the global allergy diagnostics market is expected to grow at around 11.6% CAGR throughout the forecast period of 2021 to 2031.

  • Which Is The Most Lucrative Market For Allergy Diagnostics?

    The U.S. and Canada currently lead the market for allergy diagnostics. Consistent growth throughout the assessment period can be attributed to rising prevalence of food and drug allergies, presence of developed infrastructure, and increasing consumer spending on healthcare.

  • Which End User Leads Allergy Diagnostics Market?

    Diagnostic laboratories have emerged as leading the end user in the allergy diagnostics market.

  • Who Are Some Of The Leading Players In Allergy Diagnostics Market?

    Some of the leading players operating in the allergy diagnostics market are Hitachi Chemical Co., Ltd Thermo Fisher Scientific, Inc., Siemens Healthineers, Danaher Corporation, HOB Biotech Group Co, bioMérieux, Hycor Biomedical Inc. Stallergenes Greer, R-Biopharm AG and Lincoln Diagnostics, Inc. among others.

Key Points Covered in Allergy Diagnostics Market Study

  • Market estimates and forecast 2021-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact On Allergy Diagnostics Market And How To Navigate
  • Recommendation on Key Winning Strategies

Allergy Diagnostics Market Future Outlook Brighter than 2016 - 2020 Historic Growth

According to the report by Future Market Insights, the demand for allergy diagnostics has been increasing significantly with rising prevalence of asthma and hay fever across the globe. According to a report published by World Health Organization, globally around 262 million people are impacted by asthma out of which 461,000 die from asthma.

Increasing air pollution and lack of awareness regarding food and drug allergy in emerging and poor countries are promoting market players towards developing cost effective allergy diagnostics kits.

Allergy diagnostics market experienced sluggish growth during the Covid-19 pandemic. Pandemic led to suspension of immunological care and diverted the healthcare professional towards treating COVID patients.

In case of patients with severe asthma or other allergic reaction, virtual care and limited visiting methods were employed to restrict the human contact and stop the virus transmission.

Rapid allergy molecule detection and diagnosis is a crucial part in diagnostic services. Development in fully automated immunoassay system used in in-vitro assessment of allergen molecule will reduce the testing time and improve efficacy.

In the future, the market is anticipated to grow significantly, as majority of diagnostic laboratories and hospitals are inclining towards automated allergy diagnostics for its high effectiveness. Canada and U.S are likely to yield highly opportunistic prospects, contributing towards the overall expansion of the market.

Why Is Self-Diagnosis of Allergic Reaction Becoming Popular?

According to Food Allergy Organization, nearly 200,000 Americans are sent to emergency room for severe food related allergic reaction. Rising prevalence of allergic reactions especially in children coupled with long queue and waiting time and scarcity of allergy specialist in hospitals and laboratories fueled the demand for self-diagnostic kits for allergy reaction.

User friendly interface and ease of application is promoting the adoption of allergy diagnostic among home users. Market players are trying to make them readily available in the market by strengthening their supply chain channels leading to further allergy diagnostics market growth.

“MyAllergyTest” became the stepping stone in terms of self-diagnosis domain as it is the first FDA approved allergic reaction test kit capable of testing 10 different types of allergic reactions.

Introduction of cost effective at-home food sensitivity and allergy diagnostic will boost the market growth in upcoming years. Such applications will reduce the burden on hospital and laboratories culminating to reduced allergy diagnostic and medical cost.

How Is Surge In Allergic Asthma Cases Related With Air Pollution?

According to American College of Allergy, Asthma, and Immunology, 6.1 million children and 20.4 million adults in U.S. have asthma. The prevalence of asthma is on the higher side in children than adults.

Increasing smoke and air pollution aggravates and triggers the asthma attack leading to hospitalization.  Increasing air pollution and rising prevalence of asthma in children has opened the doors for allergy diagnostics the market growth.

Self operated inhaled allergen diagnostic kits are light, simple and non invasive allergy diagnostics tool. These devices perform rapid diagnostic tests eliminating the need for healthcare infrastructure.

According to National Center for Biotechnology Information, gaseous pollutants have pro-allergic immunologic effects triggering allergic asthma attack. The market players are working towards finding protective responses to stress due to pollution and integrating it in developing allergy diagnostics for inhaled allergens.

Increasing innovation among market players towards developing rapid response allergy diagnostic kits will boost the market demand.

Country-wise Analysis

What are Allergy Diagnostics Market Drivers in the U.S?

The allergy diagnostics market in the U.S. is anticipated to follow a positive growth trajectory during the forecast period due to growing cases of peanut, milk and sea food allergies across the country.

According to report published by Asthma and Allergy Foundation of America, allergies affect around 50 million Americans every year, making it the sixth leading cause of chronic illness in the country

The rising incidence of drug allergy related death will fuel the demand for faster and efficient allergy diagnostics. Increasing incidences of skin allergies especially eczema and skin inflammation along with high rate of allergic rhinitis (hay fever) in black American population and will boost the allergy diagnostics market in U.S.

Awareness initiatives undertaken by government and non-government organization to limit the food and drug allergy related causalities will positively influence the demand of allergy diagnostics in healthcare sector.

Why Is Canada Expected To Exhibit High Market Growth?

According to Food Allergy Canada, around 3 million Canadians are affected by atleast one food allergy. Such high prevalence of food allergies heightens the risk of anaphylaxis and other complications.

Growing instances of peanut allergies and food intolerance will boost the demand for advanced allergy diagnostics.

Presence of advance healthcare infrastructure, favorable government and insurance policies and increased per capita income are key allergy diagnostics market drivers in Canada.

As per the Adverse Drug Reaction Canada, adverse drug reaction claims around 22,000 lives every year making it Canada’s fourth leading cause of death. The drug reactions also costs around US$13.7 Bn to US$ 17.7 Bn to the Canadian healthcare systems.

Rising government funding towards effective treatment and genetic testing will accelerate product demand. With improve efficiency and elevated efficacy, a healthy market growth is expected during the forecast period.

Why Is Demand For Allergy Diagnostic Kits On Rise In the U.K.?

According to the Allergy UK, more than 20% of British population is suffering for one or more allergic disorders. The report also states that nearly 44 % adults suffer from minimum one allergy.

Increasing consumer spending habits on healthcare system coupled with presence of advance healthcare system will boost the allergy diagnostics market in U.K. during the forecast period.

Increasing awareness regarding asthma and other allergic reactions like atopic eczema and hay fever will fuel the demand of allergy diagnostics.

Initiatives like “World Asthma Day” and “Beat Asthma” will elevate the demand for allergy diagnostics. Market players are working towards modifying the allergy diagnostics to promote self-administration and cater the demand for minimal invasive diagnostic measures.

How Lucrative Is The Growth Opportunity In China?

According to World Allergy Organization, in China around 500 anaphylaxis related death are reported every year. Increasing cases of food allergies will increase the chances of person going in anaphylactic shock. Rapid advancement and modernization of healthcare centers in China will create lucrative market growth opportunities.

Increasing per capita income and increased spending on healthcare will positively influence the allergy diagnostics market growth. Increasing government and private funding towards spreading asthma awareness will boost the allergy diagnostics market sales.

According to World Health Organization around 24,281 deaths due to asthma was recorded in 2018. Increasing prevalence of asthma in younger population along with elevated air pollution levels will provide momentum to allergy diagnostics market growth.

What Factors are hindering The Allergy Diagnostics Market Growth in India?

Allergy Diagnostics Market in India is expected to grow at an elevated rate throughout the forecast period. As per the data from National Health Portal of India, nearly 20% to 30% of total population in India is affected from at least one type of allergy.

Low GDP and presence of sub-optimal healthcare infrastructure are the main factors hindering the market growth in India. High prevalence of myths and stigmatic beliefs regarding asthma coupled with high rate of illiteracy is restricting the allergy diagnostics market growth.

Limited income and high cost of medicines are the main factors limiting the market growth in India. Scarcity of skilled professionals and allergy specialist and absence of super-specialist training programs in Allergy and Immunology in the country are severely affecting the market growth.

According to National Institute of Health, around 37.5 million active cases of asthma are present in India. Report also states that around 40–50% of pediatric asthma cases in India are severe.

Limited availability of allergen-specific immunotherapy for allergic rhinitis and biologics for severe asthma and lack of high quality allergen extracts for skin tests and adrenaline auto-injectors is curtailing the allergy diagnostics market growth in India.

The market scenario is expected to change in upcoming years owing to increasing government investment towards healthcare infrastructure development. Improvement in foreign direct investment policies and rising awareness regarding asthma will create novel market growth opportunities in India.

Category-wise Insights

Which End User Exhibit Higher Application of Allergy diagnostics?

Diagnostic laboratories are anticipated to generate highest demand throughout the forecast period. Rising prevalence of allergies and increasing necessity for diagnostic kits will elevate the demand of allergy diagnostics.

Why Is Food Allergy Diagnostics Becoming Popular?

By allergen type, food allergy diagnostics are expected to generate tremendous market revenue, attributed to the large population is suffering from peanuts, shellfish, dairy products and tree nuts.  Moreover, use of home based allergy diagnostics kit will help in monitoring patient’s condition until help arrives ultimately increasing the chances of survival.

What Opportunities are Prevalent in the Product Type Segment?

Demand for allergy diagnostics especially fungal allergy diagnostics is anticipated to be relatively strong, amid the rising prevalence of mold and yeast allergy in adult population. As the cases of allergy induced asthma continue to rise, market players are looking to provide low cost allergy testing kits to remote corners of the world.

Which Test Type Is Expected To Display Rapid Growth During Forecast Period?

In-vitro allergy tests are anticipated to generate highest demand throughout the forecast period. Rising demand for minimal invasive testing and increasing pollution related allergies will elevate the demand for in-vitro allergy tests.

Competitive Landscape

Allergy diagnostics market is highly competitive owing to presence of numerous established players. Market players are employing multiple marketing techniques to expand their global outreach. Allergy diagnostics market players are focusing towards employing organic and inorganic strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels. They are also emphasizing towards faster product approvals, product development and patenting.

Market players are also focusing on offering lucrative discounts and competitive pricing to increase their penetration in emerging markets.

For instance:

  • bioMérieux provides a broad range of products for allergy diagnostic. The product lineup includes VIDAS Allergy panels, mini VIDAS and VIDAS immunoassay analyzer systems. The VIDAS Allergy panels are implemented for food and respiratory allergy diagnostic.

Future Market Insights has also analyzed the following players in the allergy diagnostics market in its detailed report:

  • Hitachi Chemical Co. Ltd
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • HOB Biotech Group Co
  • bioMérieux
  • Hycor Biomedical Inc.
  • Stallergenes Greer
  • R-Biopharm AG
  • Lincoln Diagnostics Inc.

*This list is indicative - full details about the allergy diagnostics market players are available upon request.

Allergy Diagnostics Market - Report Scope

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016 - 2020

Market Analysis

US$ Mn for Value & ‘000 Units for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Middle East and Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, EU-5, BENELUX, NORDIC, Poland, Russia, Japan, China, India, Rest of South Asia , ASEAN Countries, Australia & New Zealand, Rest of East Asia, GCC Countries, South Africa, Israel, Turkey, Iran, Rest of Middle East & Africa

Key Segments Covered

By End User, By Allergen Type, By Product Type, By Test Type

Key Companies Profiled

  • Hitachi Chemical Co., Ltd
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • HOB Biotech Group Co
  • bioMérieux
  • Hycor Biomedical Inc.
  • Stallergenes Greer
  • R-Biopharm AG
  • Lincoln Diagnostics, Inc.

Report Coverage

Market Overview, Market Background, Market Forecast, Segmental Analysis, Regional Profiling and Competition Analysis

Customization & Pricing

Available upon Request

Enquiry before Buying

  • Is the market research conducted by Future Market Insights?

    Yes, the report has been compiled by expert analysts of Future Market Insights, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

  • What research methodology is followed by Future Market Insights?

    FMI follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

  • Who are the respondents for primary research?

    FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

  • What are the sources of secondary research?

    FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

  • Is a sample of this report available for evaluation?

    Yes, you can request a sample, and it will be sent to you through an email.

  • How can I buy this report?

    FMI provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely

Key Segments Covered

By Product Type

  • Fungal Allergy Diagnostic
  • Neutral Lactase Enzymes

By Allergen Type

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens

By Test Type

  • In-vivo allergy tests
  • In-vitro allergy tests

By End User

  • Diagnostic Laboratories
  • Hospitals
  • Academic Research Institutes
  • Other End Users

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports

Recommendations

Allergy Diagnostics Market